The Added Value of Quantitative 18F-FDG-PET/CT Parameters in the Assessment of Pulmonary Lymphangitic Carcinomatosis in Lung Cancer

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2020 Jan 7

PMID 31903292

Citations 3

Authors

Dexter P Mendoza

Subba R Digumarthy

Affiliations

Soon will be listed here.

Citing Articles

Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of F-Flurodeoxyglucose Positron Emission Tomography-Computed Tomography in Colorectal Cancer.

Yin Y, Xie M, Liang X, Ye M, Li J, Hu B Front Oncol. 2021; 11:741612.

PMID: 34956868 PMC: 8695495. DOI: 10.3389/fonc.2021.741612.

The Association Between Lung Fluorodeoxyglucose Metabolism and Smoking History in 347 Healthy Adults.

Tong L, Sui Y, Jiang S, Yin Y J Asthma Allergy. 2021; 14:301-308.

PMID: 33840997 PMC: 8032449. DOI: 10.2147/JAA.S302602.

Role of imaging biomarkers in mutation-driven non-small cell lung cancer.

Mendoza D, Piotrowska Z, Lennerz J, Digumarthy S World J Clin Oncol. 2020; 11(7):412-427.

PMID: 32821649 PMC: 7407925. DOI: 10.5306/wjco.v11.i7.412.

References

Munk P, Muller N, Miller R, Ostrow D . Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology. 1988; 166(3):705-9. DOI: 10.1148/radiology.166.3.3340765. View

Masson R, Krikorian J, LUKL P, Evans G, McGrath J . Pulmonary microvascular cytology in the diagnosis of lymphangitic carcinomatosis. N Engl J Med. 1989; 321(2):71-6. DOI: 10.1056/NEJM198907133210202. View

Soares F, Pinto A, Landell G, De Oliveira J . Pulmonary tumor embolism to arterial vessels and carcinomatous lymphangitis. A comparative clinicopathological study. Arch Pathol Lab Med. 1993; 117(8):827-31. View

Mendoza D, Stowell J, Muzikansky A, Shepard J, Shaw A, Digumarthy S . Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis. Clin Lung Cancer. 2019; 20(5):339-349. DOI: 10.1016/j.cllc.2019.05.006. View

Digumarthy S, Padole A, Gullo R, Sequist L, Kalra M . Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?. Medicine (Baltimore). 2019; 98(1):e13963. PMC: 6344142. DOI: 10.1097/MD.0000000000013963. View

Digumarthy S, Fischman A, Kwek B, Aquino S . Fluorodeoxyglucose positron emission tomography pattern of pulmonary lymphangitic carcinomatosis. J Comput Assist Tomogr. 2005; 29(3):346-9. DOI: 10.1097/01.rct.0000163952.03192.ef. View

JANOWER M, BLENNERHASSETT J . Lymphangitic spread of metastatic cancer to the lung. A radiologic-pathologic classification. Radiology. 1971; 101(2):267-73. DOI: 10.1148/101.2.267. View

Honda O, Johkoh T, Ichikado K, Yoshida S, Mihara N, Higashi M . Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma: is there any difference of involved interstitium?. J Comput Assist Tomogr. 1999; 23(3):374-9. DOI: 10.1097/00004728-199905000-00010. View

Jreige M, Dunet V, Letovanec I, Prior J, Meuli R, Beigelman-Aubry C . Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and F-FDG PET/CT in Correlation with Clinical Pathologic Outcome. J Nucl Med. 2019; 61(1):26-32. DOI: 10.2967/jnumed.119.229575. View

10.

Ikezoe J, Godwin J, Hunt K, Marglin S . Pulmonary lymphangitic carcinomatosis: chronicity of radiographic findings in long-term survivors. AJR Am J Roentgenol. 1995; 165(1):49-52. DOI: 10.2214/ajr.165.1.7785630. View

11.

Mak R, Digumarthy S, Muzikansky A, Engelman J, Shepard J, Choi N . Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer. Oncologist. 2011; 16(3):319-26. PMC: 3228101. DOI: 10.1634/theoncologist.2010-0300. View

12.

Biswas A, Sriram P . Getting the whole picture: lymphangitic carcinomatosis. Am J Med. 2015; 128(8):837-40. DOI: 10.1016/j.amjmed.2015.04.007. View

13.

Mendoza D, Dagogo-Jack I, Chen T, Padole A, Shepard J, Shaw A . Imaging characteristics of BRAF-mutant non-small cell lung cancer by functional class. Lung Cancer. 2019; 129:80-84. DOI: 10.1016/j.lungcan.2019.01.007. View

14.

Rami-Porta R, Bolejack V . Reply to "Inclusion of Lymphangitis as a Descriptor in the New TNM Staging of Lung Cancer: Filling Up the Blank Spaces". J Thorac Oncol. 2015; 10(12):e119-20. DOI: 10.1097/JTO.0000000000000683. View

15.

Cook G, Azad G, Owczarczyk K, Siddique M, Goh V . Challenges and Promises of PET Radiomics. Int J Radiat Oncol Biol Phys. 2018; 102(4):1083-1089. PMC: 6278749. DOI: 10.1016/j.ijrobp.2017.12.268. View

16.

Klimek M . Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018. Postgrad Med. 2019; 131(5):309-318. DOI: 10.1080/00325481.2019.1595982. View

17.

Moubax K, Wuyts W, Vandecaveye V, Prenen H . Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literature. BMC Res Notes. 2012; 5:638. PMC: 3519516. DOI: 10.1186/1756-0500-5-638. View

18.

Acikgoz G, Kim S, Houseni M, Cermik T, Intenzo C, Alavi A . Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings. Clin Nucl Med. 2006; 31(11):673-8. DOI: 10.1097/01.rlu.0000242210.99022.fd. View

19.

Charest M, Armanious S . Prognostic implication of the lymphangitic carcinomatosis pattern on perfusion lung scan. Can Assoc Radiol J. 2011; 63(4):294-303. DOI: 10.1016/j.carj.2011.04.004. View

20.

Paslawski M, Krzyzanowski K, Zlomaniec J . Lymphangitis carcinomatosa in thin section computed tomography. Ann Univ Mariae Curie Sklodowska Med. 2005; 59(1):1-5. View